Monarch Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.3M | Buy |
49,047
+275
| +0.6% | +$59.2K | 2.83% | 8 |
|
|
2026
Q1 | $10.6M | Sell |
48,772
-820
| -2% | -$182K | 2.6% | 11 |
|
|
2025
Q4 | $11.3M | Sell |
49,592
-882
| -2% | -$201K | 2.79% | 9 |
|
|
2025
Q3 | $11.7M | Sell |
50,474
-898
| -2% | -$183K | 2.87% | 7 |
|
|
2025
Q2 | $9.54M | Buy |
51,372
+29
| +0.1% | +$5.39K | 2.56% | 10 |
|
|
2025
Q1 | $10.8M | Sell |
51,343
-1,616
| -3% | -$314K | 2.99% | 8 |
|
|
2024
Q4 | $9.41M | Sell |
52,959
-393
| -0.7% | -$72.3K | 2.58% | 10 |
|
|
2024
Q3 | $10.5M | Buy |
53,352
+574
| +1% | +$107K | 2.84% | 8 |
|
|
2024
Q2 | $9.05M | Sell |
52,778
-552
| -1% | -$91.4K | 2.66% | 9 |
|
|
2024
Q1 | $9.71M | Sell |
53,330
-934
| -2% | -$161K | 2.74% | 8 |
|
|
2023
Q4 | $8.41M | Sell |
54,264
-1,185
| -2% | -$173K | 2.55% | 9 |
|
|
2023
Q3 | $8.27M | Sell |
55,449
-330
| -0.6% | -$48.4K | 2.66% | 10 |
|
|
2023
Q2 | $7.52M | Sell |
55,779
-528
| -0.9% | -$77.4K | 2.28% | 13 |
|
|
2023
Q1 | $8.97M | Sell |
56,307
-1,145
| -2% | -$175K | 2.75% | 8 |
|
|
2022
Q4 | $9.28M | Sell |
57,452
-2,653
| -4% | -$407K | 2.85% | 9 |
|
|
2022
Q3 | $8.07M | Sell |
60,105
-2,198
| -4% | -$315K | 2.63% | 11 |
|
|
2022
Q2 | $9.54M | Sell |
62,303
-623
| -1% | -$95.2K | 2.84% | 8 |
|
|
2022
Q1 | $10.2M | Sell |
62,926
-2,262
| -3% | -$329K | 2.7% | 8 |
|
|
2021
Q4 | $8.83M | Sell |
65,188
-923
| -1% | -$109K | 2.26% | 15 |
|
|
2021
Q3 | $7.13M | Buy |
66,111
+2,175
| +3% | +$249K | 1.98% | 16 |
|
|
2021
Q2 | $7.2M | Buy |
63,936
+936
| +1% | +$105K | 2.06% | 17 |
|
|
2021
Q1 | $6.82M | Buy |
63,000
+460
| +0.7% | +$49.2K | 2.02% | 20 |
|
|
2020
Q4 | $6.7M | Sell |
62,540
-1,587
| -2% | -$153K | 2.11% | 18 |
|
|
2020
Q3 | $5.62M | Buy |
64,127
+97
| +0.2% | +$9.13K | 1.95% | 21 |
|
|
2020
Q2 | $6.29M | Buy |
64,030
+877
| +1% | +$77.2K | 2.3% | 17 |
|
|
2020
Q1 | $4.81M | Buy |
63,153
+1,105
| +2% | +$94.1K | 1.96% | 21 |
|
|
2019
Q4 | $5.49M | Sell |
62,048
-25
| -0% | -$2.08K | 1.79% | 25 |
|
|
2019
Q3 | $4.7M | Buy |
62,073
+2,364
| +4% | +$162K | 1.64% | 26 |
|
|
2019
Q2 | $4.34M | Buy |
59,709
+1,855
| +3% | +$146K | 1.55% | 29 |
|
|
2019
Q1 | $4.66M | Buy |
57,854
+1,240
| +2% | +$101K | 1.69% | 25 |
|
|
2018
Q4 | $5.22M | Buy |
56,614
+1,070
| +2% | +$94.1K | 2.11% | 19 |
|
|
2018
Q3 | $5.25M | Sell |
55,544
-690
| -1% | -$65.4K | 1.9% | 24 |
|
|
2018
Q2 | $5.21M | Sell |
56,234
-2,716
| -5% | -$265K | 2% | 21 |
|
|
2018
Q1 | $5.58M | Sell |
58,950
-2,657
| -4% | -$292K | 2.15% | 19 |
|
|
2017
Q4 | $5.96M | Sell |
61,607
-8,143
| -12% | -$767K | 2.22% | 19 |
|
|
2017
Q3 | $6.2M | Sell |
69,750
-2,968
| -4% | -$226K | 2.31% | 16 |
|
|
2017
Q2 | $5.27M | Sell |
72,718
-3,020
| -4% | -$203K | 2% | 20 |
|
|
2017
Q1 | $4.93M | Sell |
75,738
-155
| -0.2% | -$9.74K | 1.81% | 24 |
|
|
2016
Q4 | $4.75M | Buy |
75,893
+194
| +0.3% | +$11.8K | 1.77% | 23 |
|
|
2016
Q3 | $4.77M | Buy |
75,699
+110
| +0.1% | +$7.12K | 1.81% | 21 |
|
|
2016
Q2 | $4.68M | Buy |
75,589
+100
| +0.1% | +$6.09K | 1.74% | 24 |
|
|
2016
Q1 | $4.31M | Buy |
75,489
+8,208
| +12% | +$457K | 1.55% | 26 |
|
|
2015
Q4 | $3.99M | Buy |
67,281
+350
| +0.5% | +$20.2K | 1.53% | 28 |
|
|
2015
Q3 | $3.64M | Sell |
66,931
-503
| -0.7% | -$32.7K | 1.48% | 31 |
|
|
2015
Q2 | $4.53M | Buy |
67,434
+216
| +0.3% | +$14.1K | 1.73% | 25 |
|
|
2015
Q1 | $3.94M | Buy |
67,218
+1,004
| +2% | +$60.7K | 1.49% | 30 |
|
|
2014
Q4 | $4.33M | Sell |
66,214
-2,200
| -3% | -$139K | 1.64% | 26 |
|
|
2014
Q3 | $3.95M | Sell |
68,414
-4,455
| -6% | -$247K | 1.58% | 27 |
|
|
2014
Q2 | $4.11M | Sell |
72,869
-1,110
| -2% | -$58.2K | 1.59% | 27 |
|
|
2014
Q1 | $3.8M | Sell |
73,979
-1,400
| -2% | -$70.8K | 1.5% | 28 |
|
|
2013
Q4 | $3.98M | Sell |
75,379
-4,495
| -6% | -$221K | 1.56% | 28 |
|
|
2013
Q3 | $3.57M | Sell |
79,874
-2,150
| -3% | -$95.3K | 1.5% | 28 |
|
|
2013
Q2 | $3.39M | Buy |
+82,024
| New | +$3.59M | 1.46% | 30 |
|
Other funds holding ABBV
ECSS
ATO
Monarch Capital Management's ABBV Position: Q2 2026 in Review
Monarch Capital Management increased its AbbVie (ABBV) stake by 0.56% in Q2 2026, buying an estimated $59.2K and bringing the position to 49,047 shares worth $12.3M. The position accounts for 2.83% of the portfolio, ranked #8.
Monarch Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Monarch Capital Management held 49,047 shares of AbbVie worth $12.3M as of Q2 2026.
- Monarch Capital Management bought 275 AbbVie shares in Q2 2026, an estimated $59.2K.
- AbbVie made up 2.83% of Monarch Capital Management's portfolio in Q2 2026, its #8 holding.
- Monarch Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.